A total of 159 patients with at least one hemoglobin measurement were included in the study with a mean ± SD age of 66.5 ± 8.3 years and post-bronchodilator FEV1 (% predicted) of 51.4 ± 17.0%. Hemoglobin values ranged from 7.9 to 18.2 g/dL, with a mean ± SD of 12.9 ± 1.4 g/dL for women and 13.8 ± 1.7 g/dL for men. 41% of patients (n = 65) were anemic at one or more study visits – “ever-anemic”. Baseline characteristics were categorized by ever-anemia status (Table 1).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile